OP Asset Management »

Alnylam Pharmaceuticals shares owned by OP Asset Management

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by OP Asset Management from 13F filings

Historical chart of OP Asset Management investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by OP Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by OP Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $9.0M 24k 382.55

More positions owned by OP Asset Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Eli Lilly & Co. (LLY)
Vertiv Holdings Com Cl A (VRT)
Johnson & Johnson (JNJ)
Wal-Mart Stores (WMT)
Parker-Hannifin Corporation (PH)
Costco Wholesale Corporation (COST)

View all positions for OP Asset Management

Top funds holding Alnylam Pharmaceuticals

Capital World Investors
FMR
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Geode Capital Management
Baillie Gifford & Co
Norges Bank Investment Management
Invesco
Dodge & Cox
T. Rowe Price Investment Management
Wellington Management Company
Orbis Allan Gray
American Century Companies

View all funds holding Alnylam Pharmaceuticals